{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:22:13Z","timestamp":1791850933727,"version":"4.3.4"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,5]]},"abstract":"<jats:p>\n                    To evaluate the effectiveness and safety of a cancer pain information platform combined with semi-implantable intrathecal drug delivery systems among the patients with refractory cancer pain under a \u201chome analgesia\u201d model. This was a retrospective study. A total of 49 patients underwent semi-implantable intrathecal drug delivery systems with patient-controlled analgesia in conjunction with the establishment of a cancer pain information platform. Numeric rating scales (NRS), Bruggrmann comfort scale (BCS), high-quality sleep duration, and opioid-related adverse effects were recorded at various time points and analyzed: the day on admission (T0), the day of discharge (T1), 30 days post-discharge (T2), 60 days post-discharge (T3), 90 days post-discharge (T4), 120 days post-discharge (T5), 150 days post-discharge (T6), 180 days post-discharge (T7), and the day before death (T8). Compared with T0, NRS significantly decreased and BCS significantly increased at T1 to T8 time points (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). However, NRS and BCS did not show differences at T1 to T8 time points (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). The duration of high-quality sleep was significantly extended, and the incidence of opioid-related adverse effects was significantly reduced. Postoperative complications included 1 case of cerebrospinal fluid leakage, 3 cases of infection at the butterfly needle insertion site, 6 cases of hospital readmission for equipment malfunction, and no cases of respiratory depression. Eleven patients continued standardized antitreatment after IDDS surgery. The mean survival time for all patients was 135.51\u2005\u00b1\u2005102.69 days, and the survival rate at T7 was 30.61%. The cancer pain information platform combined with semi-implantable IDDS is beneficial for the pain management of refractory cancer patients under the \u201chome analgesia\u201d model, improving their quality of life.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000038765","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T16:03:55Z","timestamp":1720195435000},"page":"e38765","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinical observation of the treatment of refractory cancer pain with cancer pain information platform and IDDS under home analgesia mode: A retrospective study"],"prefix":"10.1097","volume":"103","author":[{"given":"Yongyong","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Pain, The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1598-5293","authenticated-orcid":false,"given":"Hong","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Pain, The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.3390\/curroncol30070500","article-title":"Cancer pain management: a narrative review of current concepts, strategies, and techniques.","volume":"30","author":"Mestdagh","year":"2023","journal-title":"Curr Oncol"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/j.jpainsymman.2021.09.008","article-title":"The impact of optimism on cancer-related and postsurgical cancer pain: a systematic review.","volume":"63","author":"Forte","year":"2022","journal-title":"J Pain Symptom Manage"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40122-023-00507-z","article-title":"Refractory cancer pain and intrathecal therapy: critical review of a systematic review.","volume":"12","author":"Mercadante","year":"2023","journal-title":"Pain Ther"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2147\/JPR.S405808","article-title":"Early interventional treatments for patients with cancer pain: a narrative review.","volume":"16","author":"Hochberg","year":"2023","journal-title":"J Pain Res"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"900566","DOI":"10.3389\/fpain.2022.900566","article-title":"Intrathecal drug delivery: advances and applications in the management of chronic pain patient [published correction appears in Front Pain Res (Lausanne). 2023 Apr 11;4:1190014].","volume":"3","author":"De Andres","year":"2022","journal-title":"Front Pain Res (Lausanne)"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"e064581","DOI":"10.1136\/bmjopen-2022-064581","article-title":"Effects of hydromorphone-based intravenous patient-controlled analgesia with and without a low basal infusion on postoperative hypoxaemia: study protocol for a randomised controlled clinical trial.","volume":"12","author":"Ma","year":"2022","journal-title":"BMJ Open"},{"key":"R7-20260109","first-page":"5","article-title":"Management of severe cancer pain by intrathecal morphine infusion via subcutaneous port.","volume":"22","author":"Peng","year":"2016","journal-title":"Chin J Pain Med"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/ner.13167","article-title":"Patient satisfaction following intrathecal targeted drug delivery for benign chronic pain: results of a single-center survey study.","volume":"23","author":"Schultz","year":"2020","journal-title":"Neuromodulation"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.pmn.2020.11.003","article-title":"Barriers to effective cancer pain management in home setting: a qualitative study.","volume":"22","author":"Rafii","year":"2021","journal-title":"Pain Manag Nurs"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"104970","DOI":"10.1016\/j.archger.2023.104970","article-title":"The impact of home and community care services pilot program on healthy aging: a difference-in-difference with propensity score matching analysis from China.","volume":"110","author":"Su","year":"2023","journal-title":"Arch Gerontol Geriatr"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"109687","DOI":"10.1016\/j.radonc.2023.109687","article-title":"Randomized controlled study of pain education in patients receiving radiotherapy for painful bone metastases.","volume":"185","author":"Geerling","year":"2023","journal-title":"Radiother Oncol"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13019-023-02243-z","article-title":"Efficacy of preemptive intercostal nerve block on recovery in patients undergoing video-assisted thoracic lobectomy.","volume":"18","author":"Chen","year":"2023","journal-title":"J Cardiothorac Surg"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11916-013-0395-y","article-title":"Managing difficult pain conditions in the cancer patient.","volume":"18","author":"Mercadante","year":"2014","journal-title":"Curr Pain Headache Rep"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/cancers13071543","article-title":"Apoptosis-inducing TNF superfamily ligands for cancer therapy.","volume":"13","author":"Diaz Arguello","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R15-20260109","first-page":"e18837","article-title":"The practice of pain assessment and management in a tertiary oncology center.","volume":"13","author":"ALMouaalamy","year":"2021","journal-title":"Cureus"},{"key":"R16-20260109","first-page":"E414","article-title":"Rationale and recent advances in targeted drug delivery for cancer pain: is it time to change the paradigm?","volume":"25","author":"Dupoiron","year":"2022","journal-title":"Pain Physician"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.neurom.2022.03.003","article-title":"Effectiveness and safety of intrathecal drug delivery systems for the management of cancer pain: a systematic review and meta-analysis.","volume":"26","author":"Duarte","year":"2023","journal-title":"Neuromodulation"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/ner.13325","article-title":"Adverse events and complications associated with intrathecal drug delivery systems: insights from the Manufacturer and User Facility Device Experience (MAUDE) Database.","volume":"24","author":"Goel","year":"2021","journal-title":"Neuromodulation"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21037\/atm-20-3814","article-title":"Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications.","volume":"9","author":"Capozza","year":"2021","journal-title":"Ann Transl Med"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12893-021-01442-6","article-title":"Risk factors and management strategies for cerebrospinal fluid leakage following lumbar posterior surgery.","volume":"22","author":"Tang","year":"2022","journal-title":"BMC Surg"},{"key":"R21-20260109","first-page":"1125","article-title":"Clinical observation of self-controlled analgesia of wireless analgesia pump system for cancerous outbreak pain.","volume":"11","author":"Hui-jing","year":"2020","journal-title":"J Clin Expmed"},{"key":"R22-20260109","first-page":"107","article-title":"Clinical application of intelligent pain management system for cancer pain control.","volume":"21","author":"Weiwei","year":"2015","journal-title":"Chin J Pain Med"},{"key":"R23-20260109","first-page":"3","article-title":"Construction of cancer pain whole-process management system based on BYOD technology.","volume":"23","author":"Yinghao","year":"2017","journal-title":"Contemporary Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:03:24Z","timestamp":1767967404000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":23,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038765","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}